Fresenius | FRE - Cost Of Sales

Stock Price
39.65
Daily Change
0.44 1.12%
Monthly
-9.43%
Yearly
-9.95%
Q2 Forecast
37.79

Fresenius reported EUR4.45B in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Akzo Nobel EUR 1.41B 28M Mar/2026
Alcon AG USD 1.18B 26M Mar/2026
AstraZeneca USD -204M 3.48B Mar/2026
BASF EUR 11.87B 941M Mar/2026
Bayer EUR 5.23B 731M Mar/2026
Beiersdorf EUR 2.06B 50M Dec/2025
DaVita Healthcare Partners USD 2.52B 76.13M Mar/2026
Demant DKK 2.89B 188M Dec/2025
E.ON EUR 16.41B 114M Mar/2026
Essilor EUR 6.06B 741M Dec/2025
Fresenius EUR 4.45B 262M Dec/2025
Fresenius Medical Care EUR 3.43B 248M Mar/2026
Getinge SEK 6.02B 1.7B Dec/2024
Givaudan CHF 2.07B 105M Dec/2025
GlaxoSmithKline GBP 1.88B 736M Mar/2026
GN Store Nord DKK 1.16B 1.08B Mar/2026
GRIFOLS EUR 1.08B 214.82M Mar/2026
Hikma Pharmaceutical USD 959M 492.5M Dec/2025
Lonza CHF 2.28B 189M Jun/2025
Merck EUR 2.07B 219M Mar/2026
Novartis USD 3.46B 83M Mar/2026
Philips EUR 2.14B 669M Mar/2026
Roche Holding CHF 8.48B 4.61B Dec/2025
RWE EUR 3.21B 397M Mar/2026
Sanofi EUR 3.67B 621M Mar/2026
Smith & Nephew USD 870M 17M Dec/2025